Tumours, Toxins & Time

Brain tumours are a leading cause of death in children. Through studying their biology, we understand better the different types of brain tumour, their relationship to normal brain development and helped identify new treatments. MRI scans form a key part of diagnosing, treating patients and testing new therapies.  As digital images, we can and use computers and AI to learn more than is visible to the naked eye. In this talk we take a whistlestop tour of advances across these areas as well as how new clinical trial designs are helping us to accelerate how we find out whether treatments work.

‘Superbugs’ are making lung infections harder to treat. As current antibiotics become less effective, scientists are rethinking not just which antibiotics we should use, but also how we deliver them. While traditional drug delivery relies on systemic circulation, nebulisation therapy uses a fast-track delivery service: straight to the lungs, straight to the point of infection. This talk discusses how nebulisation therapy, the process of converting drugs into an inhalable mist, can be used to tackle ‘Superbugs’ and reduce off-target side effects of drugs.

A talk covering biological ageing: how, as scientists, we measure it, how sustaining a serious injury can impact the rate at which we age, and importantly, what we can do to improve how well we age - ultimately improving how long we're in good health.